Contraindicated. Coadministration not advisable; potent cytochrome P450 enzyme inducers reduce systemic publicity to roflumilast and may decrease the therapeutic success This greatly facilitated our analyze on drug-drug interactions and metabolic pathways. The thorough documentation and assistanc